Cargando…

Multi‐criteria manufacturability indices for ranking high‐concentration monoclonal antibody formulations

The need for high‐concentration formulations for subcutaneous delivery of therapeutic monoclonal antibodies (mAbs) can present manufacturability challenges for the final ultrafiltration/diafiltration (UF/DF) step. Viscosity levels and the propensity to aggregate are key considerations for high‐conce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yang, Velayudhan, Ajoy, Thornhill, Nina F., Farid, Suzanne S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575515/ https://www.ncbi.nlm.nih.gov/pubmed/28464235 http://dx.doi.org/10.1002/bit.26329

Ejemplares similares

Discovering Novel Small Molecule Compound for Prevention of Monoclonal Antibody Self-Association †
por: Lui, Lok Hin, et al.
Publicado: (2022)

Ranking and Prioritization for Multi-indicator Systems
por: Brüggemann, Rainer, et al.
Publicado: (2011)

Effects of Monovalent Salt on Protein-Protein Interactions of Dilute and Concentrated Monoclonal Antibody Formulations
por: Xu, Amy Y., et al.
Publicado: (2022)

Technological and methodical process integration in manufacturing of monoclonal antibodies
por: Gronemeyer, Petra, et al.
Publicado: (2015)

Multi-attribute Raman spectroscopy (MARS) for monitoring product quality attributes in formulated monoclonal antibody therapeutics
por: Wei, Bingchuan, et al.
Publicado: (2021)

Criteria-based ranking (CBR): A comprehensive process for selecting and prioritizing monitoring indicators
por: Ho, Elaine
Publicado: (2018)

Process Analytical Technologies and Data Analytics for the Manufacture of Monoclonal Antibodies
por: Maruthamuthu, Murali K., et al.
Publicado: (2020)

RANKING CRITERIA, LHC CRAB CAVITIES
por: Calaga, R, et al.
Publicado: (2014)

Comparison of Strategies in Development and Manufacturing of Low Viscosity, Ultra-High Concentration Formulation for IgG1 Antibody
por: Deokar, Vaibhav, et al.
Publicado: (2020)

Applications of multi-criteria and game theory approaches: manufacturing and logistics
por: Benyoucef, Lyes, et al.
Publicado: (2014)

Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration
por: Sharma, Vaneet K., et al.
Publicado: (2020)

Development and biophysical characterization of a humanized FSH–blocking monoclonal antibody therapeutic formulated at an ultra-high concentration
por: Rojekar, Satish, et al.
Publicado: (2023)

Development and Biophysical Characterization of a Humanized FSH–Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra–High Concentration
por: Rojekar, Satish, et al.
Publicado: (2023)

Developability studies before initiation of process development: Improving manufacturability of monoclonal antibodies
por: Yang, Xiaoyu, et al.
Publicado: (2013)

The New Zealand drug harms ranking study: A multi-criteria decision analysis
por: Crossin, Rose, et al.
Publicado: (2023)

In-Depth Method for the Characterization of Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs
por: Song, Ting, et al.
Publicado: (2014)

Food safety objectives, criteria, ranking and hierarchization
por: Liuzzo, Gaetano, et al.
Publicado: (2019)

Photoinitiator Selection and Concentration in Photopolymer Formulations towards Large-Format Additive Manufacturing
por: Stiles, Alex, et al.
Publicado: (2022)

Discovery of compounds with viscosity-reducing effects on biopharmaceutical formulations with monoclonal antibodies
por: Proj, Matic, et al.
Publicado: (2022)

SAT669 Development And Biophysical Characterization Of A Humanized FSH-blocking Monoclonal Antibody Therapeutic Formulated At An Ultra-high Concentration
por: Rojekar, Satish, et al.
Publicado: (2023)

Development and formulation of the classification criteria for osteoarthritis
por: Huang, Cibo, et al.
Publicado: (2020)

Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation
por: Sifniotis, Vicki, et al.
Publicado: (2019)

Stability of Monoclonal Antibodies as Solid Formulation for Auto-Injectors: A Pilot Study
por: Garcia-Villen, Fatima, et al.
Publicado: (2023)

Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture
por: Pollock, James, et al.
Publicado: (2017)

EnRICH: Extraction and Ranking using Integration and Criteria Heuristics
por: Zhang, Xia, et al.
Publicado: (2013)

Be Aggressive! Amorphous Excipients Enabling Single-Step Freeze-Drying of Monoclonal Antibody Formulations
por: Haeuser, Christina, et al.
Publicado: (2019)

Erratum to development and formulation of the classification criteria for osteoarthritis
por: Huang, Cibo, et al.
Publicado: (2020)

Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations
por: Mullan, Brian, et al.
Publicado: (2011)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

RankProt: A multi criteria-ranking platform to attain protein thermostabilizing mutations and its in vitro applications - Attribute based prediction method on the principles of Analytical Hierarchical Process
por: Chakravorty, Debamitra, et al.
Publicado: (2018)

Ranking Decision-Making Criteria for Early Adoption of Innovative Surgical Technologies
por: Shoman, Haitham, et al.
Publicado: (2023)

Characterizing monoclonal antibody formulations in arginine glutamate solutions using (1)H NMR spectroscopy
por: Kheddo, Priscilla, et al.
Publicado: (2016)

Distribution of Protein Content and Number of Aggregates in Monoclonal Antibody Formulation After Large-Scale Freezing
por: Hauptmann, Astrid, et al.
Publicado: (2019)

Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation
por: Seow, Han Cong, et al.
Publicado: (2023)

Integration of Aqueous Two-Phase Extraction as Cell Harvest and Capture Operation in the Manufacturing Process of Monoclonal Antibodies
por: Schmidt, Axel, et al.
Publicado: (2017)

Stability of two competing populations in chemostat where one of the population changes its average mass of division in response to changes of its population
por: Voulgarelis, Dimitrios, et al.
Publicado: (2019)

Ranking Technologies of Additive Manufacturing of Removable Complete Dentures by the Results of Their Mechanical Testing
por: Grachev, Dmitry I., et al.
Publicado: (2023)

Calibration of Failure Criteria for Additively Manufactured Metallic Materials
por: Socha, Grzegorz
Publicado: (2021)

Comparison of computer systems and ranking criteria for automatic melanoma detection in dermoscopic images
por: Møllersen, Kajsa, et al.
Publicado: (2017)

Data‐driven multi‐objective optimization via grid compatible simplex technique and desirability approach for challenging high throughput chromatography applications
por: Konstantinidis, Spyridon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5kr185npb1m8c6tv3t7qj678lv